SHANG.FOS.PHARM.GR.H YC 1SHANG.FOS.PHARM.GR.H YC 1SHANG.FOS.PHARM.GR.H YC 1

SHANG.FOS.PHARM.GR.H YC 1

No trades
See on Supercharts
Market capitalization
‪7.02 B‬EUR
‪307.44 M‬EUR
‪5.29 B‬EUR
‪480.33 M‬
Beta (1Y)
0.88

About SHANG.FOS.PHARM.GR.H YC 1

CEO
De Yong Wen
Headquarters
Shanghai
Employees (FY)
‪40.37 K‬
Founded
1994
ISIN
CNE100001M79
FIGI
BBG007FFXH82
Shanghai Fosun Pharmaceutical Group Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products and medical equipment, import and export of medical equipment, healthcare services, and the provision of related and other consulting services and investment management. It operates through the following business segment: Pharmaceutical Manufacturing and R&D; Healthcare Service; Medical Devices and Medical Diagnosis; Pharmaceutical Distribution and Retail; and Other Business Operations. The Pharmaceutical Manufacturing and R&D segment involves in the production, sale, and research of medicine. The Healthcare Service segment provides healthcare service and hospital management. The Medical Devices and Medical Diagnosis segment focuses on the production and sale of medical equipment and diagnostic products. The Pharmaceutical Distribution and Retail segment issue retail and wholesale of medicine. The Other Business Operations segment comprises business that is different from the role of other segments. The company was founded on January 14, 1994 and is headquartered in Shanghai, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SHANG.FOS.PHARM.GR.H YC 1 stocks are traded under the ticker 08HH.
SHANG.FOS.PHARM.GR.H YC 1 is going to release the next earnings report on Aug 26, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for SHANG.FOS.PHARM.GR.H YC 1 has a max estimate of 4.519 EUR and a min estimate of 1.725 EUR.
Yes, you can track SHANG.FOS.PHARM.GR.H YC 1 financials in yearly and quarterly reports right on TradingView.
08HH net income for the last quarter is ‪77.06 M‬ EUR, while the quarter before that showed ‪235.93 M‬ EUR of net income which accounts for −67.34% change. Track more SHANG.FOS.PHARM.GR.H YC 1 financial stats to get the full picture.
Yes, 08HH dividends are paid annually. The last dividend per share was 0.05 EUR. As of today, Dividend Yield (TTM)% is 3.99%. Tracking SHANG.FOS.PHARM.GR.H YC 1 dividends might help you take more informed decisions.
SHANG.FOS.PHARM.GR.H YC 1 dividend yield was 1.75% in 2023, and payout ratio reached 27.20%. The year before the numbers were 2.07% and 28.26% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 08HH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANG.FOS.PHARM.GR.H YC 1 stock right from TradingView charts — choose your broker and connect to your account.
08HH reached its all-time high on Aug 4, 2021 with the price of 8.620 EUR, and its all-time low was 0.270 EUR and was reached on Feb 19, 2009.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has ‪40.37 K‬ employees. See our rating of the largest employees — is SHANG.FOS.PHARM.GR.H YC 1 on this list?
We've gathered analysts' opinions on SHANG.FOS.PHARM.GR.H YC 1 future price: according to them, 08HH price has a max estimate of 4.52 EUR and a min estimate of 1.73 EUR. Read a more detailed SHANG.FOS.PHARM.GR.H YC 1 forecast: see what analysts think of SHANG.FOS.PHARM.GR.H YC 1 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHANG.FOS.PHARM.GR.H YC 1 EBITDA is ‪537.68 M‬ EUR, and current EBITDA margin is 10.23%. See more stats in SHANG.FOS.PHARM.GR.H YC 1 financial statements.